⌘K
Loading ticker…
As of 2026-08-24, vTv Therapeutics Inc. Class A Common Stock (VTVT) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.2%, relative volume 0.19×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
Share count unavailable
Reported figures from SEC filings. No analyst estimates or forward guidance.
VTVT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Held by 3 ETFs · $4M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M | — |
| VXFVanguard Extended Market ETF | 0.00% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VTVT Jan avg: 5.56% median: 2.90% win: 50% σ: 31.10% n: 4 2022-04-12 → 2026-07-31 | VTVT Feb avg: 30.79% median: 14.60% win: 75% σ: 54.02% n: 4 2022-04-12 → 2026-07-31 | VTVT Mar avg: 6.46% median: 1.83% win: 50% σ: 19.59% n: 4 2022-04-12 → 2026-07-31 | VTVT Apr avg: 4.35% median: 11.38% win: 60% σ: 15.67% n: 5 2022-04-12 → 2026-07-31 | VTVT May avg: -10.17% median: -16.38% win: 40% σ: 12.14% n: 5 2022-04-12 → 2026-07-31 | VTVT Jun avg: 2.54% median: -5.60% win: 40% σ: 22.90% n: 5 2022-04-12 → 2026-07-31 | VTVT Jul avg: -4.19% median: -8.62% win: 20% σ: 15.04% n: 5 2022-04-12 → 2026-07-31 | VTVT Aug avg: 2.55% median: 8.49% win: 75% σ: 18.59% n: 4 2022-04-12 → 2026-07-31 (current) | VTVT Sep avg: 3.84% median: -7.38% win: 25% σ: 26.81% n: 4 2022-04-12 → 2026-07-31 | VTVT Oct avg: -7.36% median: -8.89% win: 25% σ: 6.16% n: 4 2022-04-12 → 2026-07-31 | VTVT Nov avg: 5.20% median: 6.18% win: 50% σ: 17.54% n: 4 2022-04-12 → 2026-07-31 | VTVT Dec avg: -0.81% median: -16.72% win: 25% σ: 33.83% n: 4 2022-04-12 → 2026-07-31 |